insights_auto
Why is SOBI up 2,39%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
437,40 SEK
arrow_upward
+2,39%(+10,20) 1D
14-окт., 17:29:59 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
427,40 SEK
High
438,00 SEK
Low
424,80 SEK
Mkt. cap
156,43 млд
Avg. vol.
255,84 миң
Volume
360,38 миң
P/E ratio
116,82
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 млн
No. of employees
2 миң
Open
427,40 SEK
High
438,00 SEK
Low
424,80 SEK
Mkt. cap
156,43 млд
Avg. vol.
255,84 миң
Volume
360,38 миң
P/E ratio
116,82
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 млн
No. of employees
2 миң
News stories
From web sources and news partners
24/7 Wall St.
·
1 саат мурун
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
AP News
·
21 саат мурун
US hits Bank of America with $1.2 billion fine, saying it violated money laundering, sanctions laws
The Motley Fool
·
5 саат мурун
The S&P 500 Is Dangerously Concentrated in 5 Tech Giants. Are They Still Buys?
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)